EP3920970
METHOD FOR TREATING CHECKPOINT INHIBITORS INDUCED ADVERSE EVENTS
:
EP einkaleyfi: Þýðing ekki lögð inn:
3.2.2020:
23.11.2022:
20702304.5
:
2.2.2040
:
METHOD FOR TREATING CHECKPOINT INHIBITORS INDUCED ADVERSE EVENTS
3.2.2020
23.11.2022
:
Assistance Publique Hôpitaux de Paris:
3, avenue Victoria, 75004 Paris, FR
:
Sorbonne Université:
21 Rue de l'Ecole de Médecine, 75006 Paris, FR
:
Institut National de la Santé et de la Recherche Médicale (INSERM):
101 rue de Tolbiac, 75013 Paris, FR
:
Vanderbilt University:
305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37240, US
:
SALEM, Joe-Elie:
75013 PARIS, FR
:
ALLENBACH, Yves:
75013 PARIS, FR
:
KERNEIS, Mathieu:
75013 PARIS, FR
:
MOSLEHI, Javid:
NASHVILLE, Tennessee 37203, US
:
JOHNSON, Douglas:
NASHVILLE, Tennessee 37203, US
:
19305128:
4.2.2019:
EP
:
EP2020052554:
3.2.2020
:
A61K 31/506, A61P 11/00